-
Featured
Identifying Risk Factors for Type 2 Myocardial Infarction
In one of the first large systematic surveys of the frequency and implications of supply/demand-related Type 2 Myocardial Infarction, a suite of risk factors has been identified to help ensure patients receive proper care.
-
Featured
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
Damage to the mitral valve after heart attack leads to HF and death. Treatment with hypertension drug may reduce mitral valve scaring and stiffening.
-
Featured
DNA is not Destiny When it Comes to Heart Attack Risk
A study led by Sekar Kathiresan, MD, of Mass General, has found that having a favorable lifestyle can help those with a high genetic risk of having a heart attack reduce their risk by over 50%.
-
Application of Bioadhesive to Heart Improves Survival in Preclinical Model of Myocardial Infarction
Cardiac Arrhythmia Service researchers have formulated a gelatin-based bioadhesive that can be applied in liquid form to the site of myocardial infarction, then polymerized with visible-spectrum light, rapidly creating a firm but flexible scaffold to support weakened tissue and preserve left ventricular function.
-
Age Influences the Effect of Risk Factors on Development of Heart Failure
Traditional risk factors have greater discriminatory value in predicting new onset of heart failure in younger adults than in older people, according to a pooled population-based cohort study by Samantha M.A. Paniagua, Sanjiv J. Shah, MD, and Jennifer E. Ho, MD, of the Cardiovascular Research Center, and colleagues.
-
Discordance Across High-Sensitivity Troponin Assays Can Affect Management of Suspected ACS
Júlia Karády, MD, and Udo Hoffman, MD, MPH, of the Cardiovascular Imaging Research Center, observed marked discordance between high-sensitivity cardiac troponin assays that would lead to different management of patients with suspected acute coronary syndrome who had an inconclusive initial evaluation.
Myocardial Infarction Contributors
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Reverse Cardiac Remodeling May Underlie Benefit of Sacubitril/Valsartan in HFrEF
-
Pradeep Natarajan, MD, MMSc
Director, Preventive Cardiology, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Mosaic Chromosomal Alterations Increase the Risk of Diverse Infections
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
